𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: A randomized, double-blind, placebo-controlled trial

✍ Scribed by Kenneth C. Kalunian; John C. Davis Jr.; Joan T. Merrill; Mark C. Totoritis; David Wofsy; for the IDEC-131 Lupus Study Group


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
79 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II, randomized, double-blind, pl
✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National